4th - 5th September 2017
QT Hotel, Gold Coast QLD, Australia
After two successful conferences at the Liverpool Hospital in 2013 and 2015, this was the third in the Australian Diabetic Foot Conference series. We brought some of the globe’s most renowned researchers and clinicians in the fields of diabetes and foot disease to the Gold Coast, to cover the latest research, from bench-top to bedside.
The Diabetic Foot Australia (DFA) Conference 2017 Committee extended a very warm welcome to our delegates who over two days at the QT enjoyed the latest in research and practice, and meet with industry partners offering the latest products and services.
We welcomed delegates from all multidisciplinary specialties caring for people with diabetic foot disease. The conference offered unique content for everyone, from people working every day at the coalface of the disease to researchers studying the solutions of the future.
Just metres from the beach front, our delegates enjoyed a spectacular scientific and social program. Plenary lectures and workshops reflected our 2017 theme and logo: wound infection, vascular surgery, multi-disciplinary treatment and biomechanics.
from our Delegates
The 2017 conference included six internationally acclaimed speakers whose influence is critical to best practice treatment and research in diabetic foot disease around the globe.
Dr. Wolcott began his wound care practice over 11 years ago and has been practicing medicine for 28 years. He is passionate about healing his patients, which has resulted in his quest for the best medical advances in wound care.
Dr Randall Wolcott
Dr Hill is Clinical Director of Vascular Surgery with specific interests in endovascular therapy. He practices in open Vascular Surgery also with interests in Vascular Access, distal/tibial bypass grafting and Aortic surgery. He has an interest in the rational use of Vascular Intervention. He is the co-director of the Vascular/Interventional Research Group at Auckland Hospital which specialises in First in Human Vascular Intervention. He is an Investigator in 10 currently enrolling peripheral endovascular trials.
Dr Andrew Hill
MB ChB., FRACS (New Zealand)
Prof. Najafi is currently serving with Baylor College of Medicine, as Professor of Surgery and Director of Clinical Research, in the Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery. He has 20 years of experience in biomechanics and over 200 scientific publications in peer reviewed journals.
Prof Bijan Najafi
Venu is a Vascular & Vein Specialist Surgeon based in Auckland.He has started the Auckland Regional Multi-Disciplinary Diabetic Foot Service which offers clinics across various sites across Auckland including Auckland, Greenlane, North Shore & Whangarei Hospitals. His Private Practice is based at Ascot Hospital with satellite clinics in Silverdale & Warkworth.
Dr Venu Bhamidipaty
MBBS., FRACS (New Zealand)
Nicolaas Schaper is author of more than 75 publications in international, peer-reviewed journals on diabetes and related disorders. Recipient of several grants, including ZonMw and Dutch Diabetes Foundation. Scientific secretary of the International Consensus on the Diabetic Foot, Coodinator of the European Eurodiale network.
Prof Nicolaas Schaper
M.D., PhD (Netherlands)
Jaap van Netten is a human movement scientist from the Netherlands, specialized in clinical research on foot problems, most notably in people with diabetes.Van Netten is also the secretary of the International Working Group on the Diabetic Foot Editorial Board and its Prevention Working Group. In these roles he is co-authoring the evidence-based international consensus guidance on the prevention and management of foot problems in diabetes.
Dr Jaap Van Netten
The Diabetic Foot Australia Conference 2017 program boasted national and international key note speakers, Plenary sessions and interactive 'Meet the Experts' workshops. Multi-disciplinary topics covering all areas of diabetic foot disease including clinical practice and scientific evidence were included in the program.
Researchers with results from original work in the field of diabetic foot disease were encouraged to submit an abstract. From a record number of entries, 18 successful submissions were provided the opportunity to deliver an oral presentation during the conference. These sessions proved extremely popular and highlighted the newest and brightest research works from around Australia.
At the conference conclusion, Pam Chen was presented with the “DFA conference 2017 best abstract award”.
Our 2017 Partners
The Diabetic Foot Australia Conference 2017 provided our partners and exhibitors the opportunity to showcase their brand to an audience of future-focused health professionals and researchers with significant influence over the Australian clinical treatment and research sectors. With over 30 exhibitors positioned in high traffic locations across two levels, the SOLD OUT exhibition spaces were designed for maximum interaction with delegates.
2017 Platinum Partner
HARTMANN has pioneered healthcare since 1818, designing ground-breaking solutions for nearly 200 years. HARTMANN’s wound treatment solutions provide healthcare professionals and patients with reliable, effective and fast-healing products that combine clinical efficiency with comfort.
From simple to high-tech, the range is designed to offer flexibility and cost-efficiency. HARTMANN is committed to using the acquired knowledge to deliver innovations and improve outcomes in the fields of wound management and compression therapy - for healthcare professionals, health economists and patients.
In the past ten years HARTMANN has transformed dressings from ‘cover and absorb’ to therapeutic products that actively promote healing.
2017 Minor Partner
Smith & Nephew is a global medical technology company with a focus on repairing and healing the human body in three high-growth sectors: Orthopaedics, Endoscopy, Wound Management and ENT. The company creates innovative products, whose performance has earned the trust of clinicians around the world. We are very proud that every day our products help improve people's lives.
2017 Major Partner
Urgo Medical is a leading French company specialized in wound healing, offering a complete range of wound management dressings and compression bandages. Historically a European player, ranked number 3 on these markets, Urgo Medical is now also established worldwide and continuously consolidating its position in Australia.
The range of high quality and innovative products has been developed to meet the constantly changing and growing expectations of healthcare professionals, as well as to help improve the quality of care and comfort of patients. All of our proposed solutions are supported by more than 55 clinical studies, making of Urgo Medical the global leader in clinical evidence. We are committed to furthering knowledge on the treatment of wounds and injured tissues, providing wound care solutions that help restore a patient’s life to its pre-injured state.
2017 Networked Partner
ACELITY have a global commitment to advancing the science of healing. Our portfolio includes negative pressure wound therapy, advanced wound dressings, negative pressure surgical incision management, and epidermal harvesting. ACELITY™ products are designed to address Advanced Wound Therapy needs with best-in-class solutions that deliver superior clinical outcomes for patients.
Two incredible days, one amazing city
A bold, unique and memorable experience at the acclaimed boutique hotel - QT Gold Coast Hotel
The Diabetic Foot Australia Conference 2017 was brought to you by the DFA Steering Committee. The committee represented a broad range of clinical, research and industry multi-disciplinary experts from across Australia and around the globe.